Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use Taclonex Scalp® Topical Suspension safely and effectively. See full prescribing information for Taclonex Scalp® Topical Suspension. Initial U.S. Approval: 2006
Medication labelWhy this: Advisory · dailymed-prescription
Enter section text here Taclonex Scalp® Topical Suspension is indicated for the topical treatment of moderate to severe psoriasis vulgaris of the scalp in adults 18 years and older. Taclonex Scalp® Topical Suspension should not be used on the face, axillae or groin Taclonex Scalp® Topical Suspension should not be used if there is atrophy at the treatment site
- generic_name
- calcipotriene and betamethasone dipropionate
- product_names
- calcipotriene and betamethasone dipropionate
- ndc
- 54868-6091, 50222-501, 54868-6091-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en